Month: October 2019

Isracann Biosciences Launches Phase One Facility Development Program in Israel

Company aims to develop top regional cannabis brands for entry into EU marketplace VANCOUVER, BC, — October 28, 2019 – Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is pleased to provide an operative overview and update regarding facility development activities in Israel. Concurrent to...
/ Corporate News
Read More

Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements

VANCOUVER, British Columbia, Oct. 16, 2019 — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities Exchange. The Company...
/ Corporate News
Read More

Isracann Biosciences Announces Completion of the Acquisition of Isracann Holdings Inc.

VANCOUVER, British Columbia, Oct. 11, 2019) — Isracann Biosciences Inc. (fka Atlas Blockchain Group Inc.) (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce that it has completed its previously announced acquisition (the “Transaction”) of Isracann Holdings Inc. (formerly, Isracann Biosciences Inc.) (“Isracann”). Terms of the Transaction were set out in a...
/ Global Cannabis News
Read More
Contact Us